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Abstract
A 52-year-old obese woman was admitted to our institution for evaluation of dyspnea and
pulmonary hypertension (PH). Polysomnography revealed severe obstructive sleep apnea (OSA)
with an apnea hypopnea index of 99.8. Treatment with nocturnal continuous positive airway pres-
sure (CPAP) resulted in correction of daytime hypoxemia, hypercapnia, and near-normalization of
pulmonary artery pressure. To our knowledge, this is the most severe case of OSA-associated PH
(approximately70 mmHg) reported to date, and it was successfully treated with nocturnal CPAP.
This case demonstrates that OSA should be considered and polysomnography performed in all
patients with PH, irrespective of severity, and that nocturnal CPAP has therapeutic effects on both
OSA and daytime PH.
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here is a close link between obstructive sleep 
apnea (OSA) and cardiovascular diseases [1]. 
In most patients,  OSA is suspected based on clinical 
features such as witnessed apneas or excessive day-
time somnolence,  but in others,  the sleep-related 
breathing disorder is not associated with any symp-
toms or signs.  In such cases,  presentation with sys-
temic hypertension or pulmonary hypertension (PH) 
may be an important clue to underlying OSA. 
Patients with dyspnea and PH sometimes suﬀ er from 
severe OSA,  and all-night polysomnography should 
be performed in such cases.  Approximately 20ｵ of 
patients with OSA manifest mild PH [2,  3]. 
Patients conﬁ rmed to have OSA are treated with 
nocturnal continuous positive airway pressure 
(CPAP),  and CPAP has been shown to ameliorate 
OSA associated with mild PH [3ﾝ5].
　　We experienced a patient with OSA and severe 
PH,  both of which were dramatically ameliorated by 
nocturnal CPAP.  Treatment resulted in a signiﬁ cant 
reduction of daytime hypoxemia and hypercapnia, 
and normalization of pulmonary artery pressure.  We 
report this case to highlight the fact that even severe 
PH can be caused solely by OSA and can be treated 
with CPAP alone.
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A 52-year-old obese woman was admitted to our institution for evaluation of dyspnea and pulmo-
nary hypertension (PH).  Polysomnography revealed severe obstructive sleep apnea (OSA) with an 
apnea hypopnea index of 99.8.  Treatment with nocturnal continuous positive airway pressure 
(CPAP) resulted in correction of daytime hypoxemia,  hypercapnia,  and near-normalization of pul-
monary artery pressure.  To our knowledge,  this is the most severe case of OSA-associated PH 
(~70 mmHg) reported to date,  and it was successfully treated with nocturnal CPAP.  This case dem-
onstrates that OSA should be considered and polysomnography performed in all patients with PH, 
irrespective of severity,  and that nocturnal CPAP has therapeutic eﬀ ects on both OSA and daytime 
PH.
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Case Report
　　A 52-year-old obese woman visited our hospital in 
August 2003 with a chief complaint of dyspnea on 
exertion.  She had been followed up for hypertension, 
hyperlipidemia and hypothyroidism for about 9 years. 
She was treated with metoprolol (60 mg/day), 
im idapril hydrochloride (5 mg/day),  pravastatin 
(10 mg/day),  and levothyroxine sodium (60 µg/day) 
and was under good control.  The past history 
included right total mastectomy for breast cancer 
with no relapse over the 15 postoperative years.  One 
month before the current presentation,  she developed 
shortness of breath on exertion with pretibial edema, 
which progressively worsened.  Twelve-lead electro-
cardiography revealed normal sinus rhythm with neg-
ative T wave in V1 through V3.  Echocardiography 
displayed right atrial and ventricular dilatation and 
pericardial eﬀ usion,  which had not been documented 
previously (Fig.  1).  Pulmonary artery pressure was 
estimated at about 70 mmHg.  Physical ﬁ ndings 
including obesity were suggestive of pulmonary 
thromboembolism.
　　She was admitted to the hospital for further eval-
uation of dyspnea and PH.  At the time of admission, 
her height was 153 cm,  her body weight was 100 kg 
and her body mass index was 42.7 kg/m2.  Physical 
examination revealed an arterial blood pressure of 
138/96 mmHg and heart rate of 92 beats/min. 
Arterial blood gas analysis revealed a carbon dioxide 
partial pressure (PaCO2) of 55.6 torr,  oxygen partial 
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Fig. 1　　Echocardiography on admission.
Night Hypnogram
Fig. 2　　Polysomnography : An overnight summary demonstrating the presence of OSA.  HR,  heart rate ; SaO2,  atrial oxygen satura-
tion by pulse oximetry ; Stage,  sleep stage ; WKMVT,  movement when awake ; REM,  rapid eye movement ; S1ﾝ4,  non-rapid eye 
movement sleep ; CA,  central apnea ; OA,  obstructive apnea ; MA,  mixed apnea ; HYPO,  hypopnea.
2
Acta Medica Okayama, Vol. 60 [2006], Iss. 3, Art. 7
http://escholarship.lib.okayama-u.ac.jp/amo/vol60/iss3/7
pressure (PaO2) of 45.9 torr,  and oxygen saturation 
(SaO2) of 82.8ｵ.  There was no cyanosis or ﬁ nger 
clubbing.  Jugular venous pressure could not be 
assessed because of obesity.  No abnormal sounds 
were heard on cardiac or lung auscultation. 
Abdominal examination revealed no hepatomegaly or 
ascites.
　　A chest radiograph showed cardiomegaly with a 
cardiothoracic ratio of 62ｵ and no abnormality of 
either lung ﬁ eld.  Multislice CT scan with contrast 
enhancement revealed no evidence of pulmonary 
embolism,  deep vein thrombosis or other abnormali-
ties.  Lung ventilation-perfusion scintigraphy did not 
yield any ﬁ ndings supporting a diagnosis of pulmo-
nary embolism.  As she was a non-smoker and her 
lung function tests were normal,  chronic obstructive 
pulmonary disease was ruled out.
　　During the examination of echocardiography,  the 
patient fell asleep,  and snoring and repetitive apneas 
were observed.  Obstructive sleep apnea (OSA) was 
then suspected.  A diagnostic full-night polysomnog-
raphy was performed (Alice 4 Sleep Diagnostic 
System ; Respironics,  Inc.,  PA,  USA) (Fig.  2).  The 
apnea hypopnea index was 99.8 per hour.  The lon-
gest apnea lasted for 82 sec (Fig.  3).  The mean 
SaO2 was 69ｵ and the minimum SaO2 was as low as 
34ｵ.  Most of the apneic episodes were obstructive 
(91.0ｵ),  while 0.3ｵ were central and 2.5ｵ were 
scored as hypopneas.  She had predominantly OSA. 
She was subsequently treated with nocturnal continu-
ous positive airway pressure (CPAP ; REMstar 
Auto ; Respironics Inc.,  Murrysville,  PA,  USA). 
Following the application of CPAP,  she immediately 
felt more alert during the daytime.  She was able to 
read books again,  something she had previously been 
unable to do for more than a few minutes without 
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Fig. 3　　Polysomnographic record demonstrating the longest OSA lasting 82 sec.  C3,  C4,  O1 and O2 : the 4 channels of the electroen-
cephalogram ; LEOG and REOG,  the 2 channels of the electrooculogram ; CHIN,  chin muscle electromyogram ; ECG,  electrocardio-
gram ; H.RATE,  heart rate ; LEMG,  leg muscle electromyogram ; FLOW,  oronasal airﬂ ow ; CHEST and ABD,  motion of the chest and 
abdominal wall ; SNORE,  snoring sound ; SaO2,  atrial oxygen saturation by pulse oximetry ; Body,  body position ; STAGE,  sleep stage.
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falling asleep.
　　Treatment with nocturnal CPAP resulted in 
improvement of daytime dyspnea and PH.  Six days 
after starting CPAP,  daytime arterial blood gas 
analysis revealed PaCO2 of 46.9 torr,  PaO2 of 73.5 
torr,  and SaO2 of 95.3ｵ on room air breathing. 
Echocardiography showed a normal size right atrium 
and slightly dilated ventricle,  and the pericardial 
eﬀ usion had disappeared.  Pulmonary artery pressure 
was estimated at 37 mmHg.  With a mean airway 
pressure of 7.4 cm H2O,  the apnea hypopnea index 
diminished to 5.2 per hour.  After discharge from the 
hospital,  she continued to use nocturnal CPAP.  She 
has been followed for over 2 years,  and dyspnea and 
PH have not recurred.
Discussion
　　Several studies have examined the relation 
between sleep-disordered breathing and cardiovascu-
lar risk [1].  OSA is the most common form of sleep-
disordered breathing and plays a role in the patho-
genesis in systemic hypertension,  congestive heart 
failure,  arrhythmias,  and atherosclerosis.  It also 
correlates with PH.  It is reported that approxi-
mately 20ｵ of OSA patients without any other lung 
or heart disease develop mild PH [2,  3].  Alchanatis 
et al. reported that the emergence of PH is related to 
old age,  greater body mass index and low PaO2 dur-
ing wakefulness [3].  In the present case,  the patient 
was 52 years old,  had a body mass index of 43 kg/m2, 
and manifested severe daytime hypoxemia on admis-
sion.  According to the criteria of Alchanatis et al., 
she was thus highly susceptible to severe OSA with 
PH.  Moreover,  the case presentation corresponded 
with Pickwickian syndrome,  which is characterized 
by severe obesity,  daytime sleepiness,  hypercapnia, 
and severe OSA [2].
　　The patient’s pulmonary artery pressure was esti-
mated as 70 mmHg,  and we were initially skeptical 
that OSA alone could have induced such severe PH. 
Patients with OSA generally have mild PH.  In the 
42 pulmonary hypertensive patients investigated by 
Laks et al.,  pulmonary artery pressure ranged from 
20 to 52 mmHg and the average value was only 
29 mmHg [6].  Similarly,  in the 37 pulmonary hyper-
tensive patients reported by Chaouat et al.,  pulmo-
nary artery pressure ranged from 20 to 44 mmHg 
with an average of 26 mmHg [7].  Because OSA is 
the only disease known to cause daytime hypoxemia 
and PH,  we ﬁ nally concluded that the severe PH in 
this patient was a complication of OSA.  This is the 
ﬁ rst reported case of OSA associated with PH of 
this severity.
　　In patients with OSA,  the combination of marked 
nocturnal hypoxemia with mild to moderate daytime 
hypoxemia could explain the development of PH.  The 
mechanisms by which alveolar hypoxia leads to PH 
are thought to be both pulmonary vasoconstriction 
and remodeling of the pulmonary vascular bed [7]. 
Obesity-related hypoventilation may also play a role 
in the emergence of mild daytime hypoxemia and sub-
sequently of mild PH [3].
　　When patients are diagnosed with OSA,  the stan-
dard treatment is nocturnal nasal CPAP [3ﾝ5].  The 
eﬀ ect of CPAP treatment on pulmonary hemodynam-
ics and gas exchange in OSA has been thoroughly 
investigated.  Sajkov et al. reported a decrease in 
pulmonary artery pressure and pulmonary vascular 
resistance in patients treated with CPAP [4].  They 
also assessed the hypothesis that CPAP could reduce 
hypoxic pulmonary vascular reactivity,  which is the 
propensity of the pulmonary circulation to constrict 
in response to a hypoxic stimulus.  In our case,  day-
time hypoxemia,  hypercapnia,  and PH improved 
markedly following treatment with CPAP,  indicating 
that intermittent nocturnal hypoxemia associated 
with OSA causes pulmonary constriction,  which is 
reversible with abolition of OSA by CPAP.
　　Conclusion. 　In this case,  administration of 
nocturnal CPAP signiﬁ cantly improved not only 
OSA but also daytime hypoxemia,  hypercapnia,  and 
severe PH.  This suggests that OSA was the only 
cause of severe PH.  Obese patients who present 
with dyspnea,  hypoxemia or PH,  even if it is severe 
PH,  should be suspected of having OSA and full-
night polysomnography should be performed. 
Moreover,  treatment of such patients with CPAP 
will result in the disappearance of symptoms and nor-
malization of pulmonary artery pressure.
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